Raymond James Financial Services Advisors, Inc. - EVOKE PHARMA INC ownership

EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 26 filers reported holding EVOKE PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Raymond James Financial Services Advisors, Inc. ownership history of EVOKE PHARMA INC
ValueSharesWeighting
Q1 2022$54,000
-10.0%
108,5450.0%0.00%
Q4 2021$60,000
-57.4%
108,5450.0%0.00%
Q3 2021$141,000
-13.5%
108,545
-8.9%
0.00%
Q2 2021$163,000119,1900.00%
Other shareholders
EVOKE PHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 259,100$1,355,0000.54%
Knoll Capital Management, LLC 55,660$291,0000.09%
Financial Architects, Inc 2,150$11,0000.00%
Tower Research Capital LLC (TRC) 1,396$7,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 15,864$82,0000.00%
BlackRock Investment Management, LLC 489$3,0000.00%
DEUTSCHE BANK AG\ 1,062$5,0000.00%
MORGAN STANLEY 1,661$9,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 36,700$192,0000.00%
Renaissance Technologies 13,024$68,0000.00%
View complete list of EVOKE PHARMA INC shareholders